Frequently Asked Questions (FAQs)
Q: What is Pharmacovigilance?
A: Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or other medicine-related problems.
Q: What is an adverse event?
A: An adverse event is any unwanted medical occurrence that happens after the use of a medicinal product, whether or not it is considered related to the medicine.
Q: Who can report an adverse event?
A: Patients, caregivers, healthcare professionals, and other individuals can report suspected adverse events.
Q: When should I report a suspected adverse event
A: You should report any suspected adverse event as soon as possible, particularly if you experience an unexpected, serious, or concerning reaction while using a medicine.
Q: Do I need to be certain that the medicine caused the event before reporting?
A: No. You do not need to be certain that the medicine caused the event. If you suspect a possible association, you are encouraged to report it.
Q: How can I report a suspected adverse event?
A: You can report through our available reporting channels, including PV-Radar, the Iraqi Pharmacovigilance Centre QR code, or directly to the Iraqi Ministry of Health through the contact details provided on this website.
Q: Why is reporting adverse events important?
A: Adverse event reports provide important safety information that contributes to the continuous monitoring and evaluation of medicines and supports their safe and appropriate use.
Q: Can I report an adverse event that is already mentioned in the package leaflet?
A: Yes. Suspected adverse events can still be reported even when they are already described in the package leaflet. Such reports may provide additional information about the nature, severity, frequency, or circumstances of the event.
